Moreover, RNF43 mutations were frequently found in sessile serrated lesions (SSLs) and MSI‐type CRC, suggesting that RNF43 mutation drives CRC development through the serrated pathway (Figure 6E). This evidence concerns the gene RNF43 and colorectal carcinoma.